Trials / Unknown
UnknownNCT03159884
The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy of intravitreal injection of 0.5 mg conbercept in patients with polypoidal choroidal vasculopathy (PCV) and explore the optimal route of administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Conbercept |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2018-06-01
- Completion
- 2018-12-01
- First posted
- 2017-05-19
- Last updated
- 2017-07-19
Locations
35 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03159884. Inclusion in this directory is not an endorsement.